Procaps Group SA PROC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $2.16
- Day Range
- $2.23–2.29
- 52-Week Range
- $1.68–4.95
- Bid/Ask
- $2.24 / $2.29
- Market Cap
- $251.60 Mil
- Volume/Avg
- 6,236 / 5,490
Key Statistics
- Price/Earnings (Normalized)
- 73.26
- Price/Sales
- 0.55
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- 0.38%
Company Profile
Procaps Group SA is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. It develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements, and high-potency clinical solutions. The company's segment includes NextGel; Procaps Colombia; CAN; CASAND and Diabetrics. It generates maximum revenue from the Procaps Colombia segment.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 5,500
- Website
- https://www.procapsgroup.com
Comparables
Valuation
|
Metric
|
PROC
|
002864
|
300254
|
|---|---|---|---|
Price/Earnings (Normalized) | 73.26 | 24.67 | 54.99 |
Price/Book Value | 6.39 | 1.75 | 3.20 |
Price/Sales | 0.55 | 2.86 | 2.42 |
Price/Cash Flow | 4.95 | 16.80 | 13.57 |
Price/Earnings
PROC
002864
300254
Financial Strength
|
Metric
|
PROC
|
002864
|
300254
|
|---|---|---|---|
Quick Ratio | 0.97 | 3.66 | 0.62 |
Current Ratio | 1.47 | 3.89 | 0.99 |
Interest Coverage | 2.77 | 27.93 | 7.89 |
Quick Ratio
PROC
002864
300254
Profitability
|
Metric
|
PROC
|
002864
|
300254
|
|---|---|---|---|
Return on Assets (Normalized) | 0.21% | 5.20% | 2.40% |
Return on Equity (Normalized) | 7.45% | 7.55% | 6.19% |
Return on Invested Capital (Normalized) | 10.39% | 5.71% | 4.44% |
Return on Assets
PROC
002864
300254
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Tfxqfjfq | Wths | $88.3 Bil | |||
| Merck KGaA ADR
MKKGY
| Hflcyczl | Lrpxphf | $78.0 Bil | |||
| Haleon PLC ADR
HLN
| Qtjnmzzzk | Yhgsx | $48.4 Bil | |||
| Viatris Inc
VTRS
| Ktkdtjdjt | Kntwy | $13.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Jyngcdyw | Mmg | $13.5 Bil | |||
| Catalent Inc
CTLT
| Tqgjysnsw | Nckxf | $10.9 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Tmgfzwb | Bcdxr | $3.5 Bil | |||
| Perrigo Co PLC
PRGO
| Jbkfshnb | Jyxds | $3.5 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Zprdyjln | Gqsy | $2.5 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Nywbbjbh | Zyfq | $2.3 Bil |
United States